Glucotrol Xl

Glucotrol Xl is a prescription oral medication whose active ingredient is glipizide. It belongs to the sulfonylurea class of antidiabetic agents and is marketed in the European Union. The product is formulated for oral administration, although the specific dosage strength and tablet form are not disclosed in the available data.

Glucotrol Xl is indicated for the management of type 2 diabetes mellitus in adults when diet, exercise, and other non‑pharmacologic measures are insufficient. It is used as part of a comprehensive diabetes care plan to improve glycemic control.

- Adjunct to diet and exercise for type 2 diabetes - May be combined with other oral antidiabetic agents - Helps lower fasting and post‑prandial blood glucose levels - Used when other monotherapy options are inadequate - Considered for patients who respond to sulfonylurea therapy

Glucotrol Xl can cause a range of side effects, most of which are mild and transient. Serious adverse reactions are less common but require medical attention.

Common: - Hypoglycemia (low blood sugar) - Nausea or abdominal discomfort - Weight gain - Dizziness or light‑headedness - Headache

Serious: - Severe allergic reactions (rash, swelling, difficulty breathing) - Hemolytic anemia - Liver function abnormalities - Pancreatitis - Persistent low blood glucose requiring assistance

Before starting Glucotrol Xl, patients should discuss their medical history and current health status with a healthcare professional. Certain conditions and factors increase the risk of adverse outcomes.

- Known hypersensitivity to glipizide or sulfonylureas - History of severe hypoglycemia - Significant renal or hepatic impairment - Pregnancy, breastfeeding, or planning pregnancy - Elderly patients may be more susceptible to hypoglycemia - Concomitant use of other glucose‑lowering agents

Glucotrol Xl may interact with other medications, affecting its efficacy or safety. Some combinations should be avoided, while others require careful monitoring.

Avoid: - Other sulfonylureas or insulin secretagogues - Strong CYP2C9 inhibitors (e.g., fluconazole, amiodarone) - Medications that can cause hypoglycemia (e.g., quinine)

Use with caution: - Beta‑blockers (may mask hypoglycemia symptoms) - Thiazide diuretics (can increase blood glucose) - NSAIDs and aspirin (may affect renal function) - Anticoagulants (potential for altered blood sugar control)